TP53 and acute myeloid leukemia: Targeted next-generation sequencing revealed a pathogenic somatic mutation in TP53 as well as variants of unknown significance in ASXL1, FAS, and PIK3CA. AML with myelodysplasia-related changes was diagnosed based on his TP53 mutation and complex karyotype.